(Q33446629)

English

A phase II study of alpha-difluoromethylornithine (DFMO) for the treatment of metastatic melanoma

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

A phase II study of alpha-difluoromethylornithine (DFMO) for the treatment of metastatic melanoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

metastatic melanoma

1 reference

based on heuristic

inferred from title

Frank L. Meyskens, Jr.

1

object named as

Meyskens FL

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Kingsley EM

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Glattke T

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Loescher L

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Booth A

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

1 January 1986

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Investigational New Drugs

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

257-262

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Polyamine metabolism and function

1 reference

https://pubmed.ncbi.nlm.nih.gov/3102397

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancement of the antiproliferative activity of human interferon by polyamine depletion

1 reference

https://pubmed.ncbi.nlm.nih.gov/3102397

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New drugs in ovarian cancer and malignant melanoma: in vitro phase II screening with the human tumor stem cell assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/3102397

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DTIC (NSC-45388) in malignant melanoma: a perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/3102397

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potentiation of the antitumor therapeutic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea by alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3102397

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-proliferative properties of DL-alpha-difluoromethyl ornithine in cultured cells. A consequence of the irreversible inhibition of ornithine decarboxylase

1 reference

https://pubmed.ncbi.nlm.nih.gov/3102397

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/3102397

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of cloned human leukocyte interferons in the human tumor stem cell assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/3102397

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of alpha-difluoromethylornithine on the growth of 9L rat brain tumor multicellular spheroids and their response to 1,3-bis(2-chloroethyl)-1-nitrosourea

1 reference

https://pubmed.ncbi.nlm.nih.gov/3102397

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergistic action of two polyamine antimetabolites leads to a rapid therapeutic response in childhood leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/3102397

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of human melanoma colony formation by retinoids

1 reference

https://pubmed.ncbi.nlm.nih.gov/3102397

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial and pharmacokinetic studies of alpha-difluoromethylornithine--an inhibitor of polyamine biosynthesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/3102397

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of alpha-difluoromethylornithine, an enzyme-activated irreversible inhibitor of ornithine decarboxylase, on L1210 leukemia in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/3102397

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00179593

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33446629&oldid=2195371679"